News • Terahertz imaging

An improved method of detecting breast cancer

Engineering researchers at the University of Arkansas have moved closer to developing an alternative method of detecting and possibly treating breast cancer. Terahertz images of breast tumors taken from mice accurately detected cancerous tissue with a high level of specificity.

Photo
Magda El-Shenawee, Professor of Electrical Engineering, University of Arkansas.
Source: Russell Cothren, University Relations, University of Arkansas.

The researchers, led by Magda El-Shenawee, professor of electrical engineering, work with pulsed, terahertz imaging, a type of electromagnetic radiation technology previously used to find land mines. They adapted the technology to detect tumors and provide highly specific images of them. Standard breast cancer imaging techniques do not always provide clear assessment of breast tissue on the margins of a tumor. Without an accurate picture of the margins between the tumor and healthy tissue, surgeons cannot be sure they have removed the entire tumor during a surgery.

This shortcoming contributes to high rates – 20 to 40 percent – of secondary surgery, either lumpectomy or mastectomy. Terahertz imaging could lead to fast, noninvasive, and highly specific tumor margin assessment, which in turn could reduce the occurrence of second surgeries, cancer reoccurrence and metastasis.

Findings

In their most recent study, the researchers created terahertz images of breast adenocarcinoma cells, a type of malignancy, excised from mice. These images were taken from 13 tumor samples. To test the accuracy of the terahertz method, the images were then statistically compared to high-resolution histopathology images of the same excised tumor samples. Histopathology is the microscopic examination of tissue changes caused by disease.

In all tissue samples containing only cancer and fat – a combination similar to tissue in the human breast – the terahertz images, when compared to the histopathology images, accurately detected cancerous tissue with a high level of specificity. On the other hand, samples containing cancer, fat and muscle showed only a reasonable correlation, El-Shenawee said. In these samples, the terahertz images detected cancer cells at the margins of tumors and muscle tissue, but not at high enough levels of specificity. “Overlap between muscle and cancer tissue in the terahertz image creates some challenge in correctly classifying these regions,” El Shenawee said. “While muscle is unlikely to be present in surgical sections of human breast cancer, other kinds of fibrous tissue may be, so this requires further investigation with more advanced models.”

Future work will focus on spontaneously generated breast cancer tumors from genetically modified mice, which have tumor and tissue structures closer to that of humans. El-Shenawee said these models will provide a more accurate assessment of terahertz imaging. The researchers will also compare the terahertz images to other standard imaging techniques, such as radiography and computed tomography, or CT scan.

Terahertz imaging

Pulsed, terahertz spectroscopy produces high-quality images of the tissue, down to 80 micrometers. It scatters fewer waves than radiography, which enables deeper imaging into an object. Also, because terahertz radiation can transmit through most non-metallic materials, the systems can “see” through concealing barriers. For many years, El-Shenawee has focused on developing this detection system for health-care applications, while also investigating the unique electromagnetic signals emitted by breast cancer cells.

Source: University of Arkansas, Fayetteville

05.03.2018

Read all latest stories

Related articles

Photo

News • Contrast-enhanced mammography vs. MRI

Neoadjuvant therapy response in breast cancer

Contrast-enhanced mammography (CEM) may be a useful alternative test for neoadjuvant therapy (NAT) response assessment in patients with breast cancer who are unable to undergo MRI.

Photo

News • Breast cancer

Giving patients an average survival time is more often wrong than right

Doctors who give advanced breast cancer patients just one estimate, such as 12 months, for the average amount of time they are expected to live are only accurate 20-30% of the time, according to Dr…

Photo

Article • Tomosynthesis

Catching more invasive cancers earlier

What beats digital mammography to detect breast cancer in asymptomatic women? Digital breast tomosynthesis (DBT) – was a big discussion at RSNA 2017. Sarah M Friedewald MD, medical director of the…

Related products

AB-CT – Advanced Breast-CT – nu:view

Mammo CT

AB-CT – Advanced Breast-CT – nu:view

AB-CT – Advanced Breast-CT GmbH
Fujifilm – AMULET Innovality

Tomosynthesis

Fujifilm – AMULET Innovality

FUJIFILM Europe GmbH
Fujifilm – AMULET Innovality Harmony

Tomosynthesis

Fujifilm – AMULET Innovality Harmony

FUJIFILM Europe GmbH
Hologic – 3DQuorum SmartSlices

Artificial Intelligence

Hologic – 3DQuorum SmartSlices

Hologic, Inc.
Hologic – Affirm Contrast Biopsy*

Biopsy Units

Hologic – Affirm Contrast Biopsy*

Hologic, Inc.
Subscribe to Newsletter